What is the magic yeast - Saccharomyces boulardii?

Saccharomyces boulardii, commonly known as the "magic yeast," is a probiotic yeast strain that has been extensively studied for its beneficial effects on gut health. This unique yeast strain is not a part of the normal gut microbiota, but it has been found to colonize the gut and exert several positive effects on the host. In this response, we will provide an overview of Saccharomyces boulardii, its potential health benefits, and the scientific evidence supporting its use.

Overview:

• Saccharomyces boulardii is a non-pathogenic yeast strain that is resistant to stomach acid and bile salts, allowing it to survive passage through the gastrointestinal tract and colonize the gut.
• It was first isolated from lychee and mangosteen fruit in 1923 by French scientist Henri Boulard, and has since been extensively studied for its probiotic properties.
• Unlike other probiotics, which are bacteria, Saccharomyces boulardii is a yeast and belongs to the same family as baker's yeast (Saccharomyces cerevisiae).
• It is available as a dietary supplement and is often used to support digestive health and treat various gastrointestinal disorders.

Potential Health Benefits:

• Supports gastrointestinal health: Saccharomyces boulardii has been found to help maintain the balance of beneficial bacteria in the gut, support the intestinal barrier function, and reduce inflammation in the gut.
• Helps prevent and treat diarrhea: Numerous clinical trials have shown that Saccharomyces boulardii can effectively prevent and treat various types of diarrhea, including antibiotic-associated diarrhea, traveler's diarrhea, and Clostridium difficile infection.
• Reduces symptoms of irritable bowel syndrome (IBS): Some studies have suggested that Saccharomyces boulardii may help reduce abdominal pain, bloating, and other symptoms of IBS.
• Supports immune function: Saccharomyces boulardii has been found to stimulate the production of secretory immunoglobulin A (sIgA), an important component of the immune system that helps protect the body against pathogens.
• Helps protect against gut dysbiosis: Saccharomyces boulardii has been found to help protect against gut dysbiosis, which is an imbalance of the gut microbiota that has been linked to various health problems.

Scientific Evidence:

• A meta-analysis of 23 randomized controlled trials found that Saccharomyces boulardii significantly reduced the risk of antibiotic-associated diarrhea.
• Another meta-analysis of 31 clinical trials found that Saccharomyces boulardii was effective in preventing and treating Clostridium difficile infection.
• A double-blind, placebo-controlled study of 57 patients with IBS found that Saccharomyces boulardii significantly reduced abdominal pain, bloating, and other symptoms.
• Animal studies have shown that Saccharomyces boulardii can reduce gut inflammation and improve gut barrier function.
• A study in healthy volunteers found that Saccharomyces boulardii increased the production of sIgA, suggesting that it may have immune-boosting effects.

In summary, Saccharomyces boulardii is a unique probiotic yeast strain that has been found to have several potential health benefits, particularly for digestive health. The scientific evidence supporting its use is robust, and it is considered safe and well-tolerated for most people.  

Questions: contact us at support@layerorigin.com

About Layer Origin: At Layer Origin, we are dedicated to unlocking the potential of Human Milk Oligosaccharides (HMOs). We believe that only God's gift could be so perfectly designed to support our gut health. Our goal is to make this super prebiotic available for both children and adults. Check out PureHMO and SuperHMO Prebiotics

References:

McFarland LV. Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World J Gastroenterol. 2010;16(18):2202-2222. doi: 10.3748/wjg.v16.i18.2202

Dinleyici EC, Eren M, Ozen M, Yargic ZA, Vandenplas Y. Effectiveness and safety of Saccharomyces boulardii for acute infectious diarrhea. Expert Opin Biol Ther. 2012;12(4):395-410. doi: 10.1517/14712598.2012.668013

McFarland LV. Evidence-based review of probiotics for antibiotic-associated diarrhea and Clostridium difficile infections. Anaerobe. 2009;15(6):274-280. doi: 10.1016/j.anaerobe.2009.09.002

McFarland LV. Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World J Gastroenterol. 2010;16(18):2202-2222. doi: 10.3748/wjg.v16.i18.2202

Kabbani TA, Pallav K, Dowd SE, et al. Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers. Gut Microbes. 2017;8(1):17-32. doi: 10.1080/19490976.2016.1267896

Dinleyici EC, Eren M, Ozen M, Yargic ZA, Vandenplas Y. Saccharomyces boulardii for prevention of necrotizing enterocolitis in preterm infants: a randomized, controlled study. Acta Paediatr. 2013;102(12):e560-e565. doi: 10.1111/apa.12414

McFarland LV. Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World J Gastroenterol. 2010;16(18):2202-2222. doi: 10.3748/wjg.v16.i18.2202

Ihekweazu FD, Versalovic J. Development of the Pediatric Gut Microbiome: Impact on Health and Disease. Am J Med Sci. 2018;356(5):413-423. doi: 10.1016/j.amjms.2018.06.011

Wohlgemuth S, Haller D, Blaut M, Loh G. Reduced microbial diversity and high numbers of one single Escherichia coli strain in the intestine of colitic mice. Environ Microbiol. 2009;11(6):1562-1571. doi: 10.1111/j.1462-2920.2009.01893.x

Zhou X, Brown CJ, Abdo Z, Davis CC, Hansmann MA, Joyce P, Foster JA, Forney LJ. Differences in the composition of vaginal microbial communities found in healthy Caucasian and black women. ISME J. 2007 Aug;1(2):121-33. doi: 10.1038/ismej.2007.12. PMID: 18043614.